This week shares of Celsion Corp. were soaring over 80% and racing to a new six month high. The reason for the big move came after Wall Street learned that the cancer drug development company disclosed that it terminated the share purchase agreement with Lincoln Park Capital (LPC). With trading volume at 18.9 million shares, … Continue reading “Celsion Terminates Share Sale Agreement with LPC and Sees Big Gains”
